Clinical Trial Update: A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating pCAR-19B for CD19-positive relapsed/refractory B-cell acute lymphoblastic leukemia in children and adolescents; recruitment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• pCAR-19B

Snippet

Sponsor: Chongqing Precision Biotech Co., Ltd | Conditions: Acute Lymphoblastic Leukemia, Relapsed Pediatric ALL | Phase 2 | Status: RECRUITING